Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
SFC Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Biomarx logo51-200 employees
Biomarx delivers rapid, low-cost, fully automated liquid biopsy — genomic-grade cancer answers from a blood test in under 2 hours, starting…
DELFI DiagnosticsVenture round $225M · 4 yr ago • Founded 2019 • 51-200 employees • 5 roles
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI…
GenomateConvertible Note $2M · 19 mo ago • Founded 2022 • 51-200 employees
Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their…
Eupnoos51-200 employees
Eupnoos develops digital biomarkers of cardiopulmonary change. Vita captures. SounDx-FM analyses. INFER supports interpretation.
Meet Vesynta, the UK team behind DosoLogic and PMX.Community, building a model-informed precision dosing ecosystem for safer, personalised…
Blank BioSeed $7.2M · 4 mo ago • 11-50 employees
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for…

Overview

Precious MD is developing a companion diagnostic to identify the lung cancer patients who benefit from receiving EGFR inhibiting ...